BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $163.6 million in its first quarter.
The Bridgewater, New Jersey-based company said it had a loss of 76 cents per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $306 million in the period, which missed Street forecasts. Seven analysts surveyed by Zacks expected $308.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
/Palantir%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock.jpg)
/Dell%20Technologies%20by%20Poetra_RH%20via%20Shutterstock.jpg)
